Erlotinib-induced acute hepatitis in a patient with pancreatic cancer

Clin Adv Hematol Oncol. 2008 Mar;6(3):191-199.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / enzymology
  • Antimetabolites, Antineoplastic / therapeutic use
  • Chemical and Drug Induced Liver Injury / etiology*
  • Cytochrome P-450 Enzyme System / drug effects
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • ErbB Receptors / antagonists & inhibitors*
  • Erlotinib Hydrochloride
  • Gemcitabine
  • Humans
  • Liver / enzymology
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / enzymology
  • Protein Kinase Inhibitors / adverse effects*
  • Quinazolines / adverse effects*

Substances

  • Antimetabolites, Antineoplastic
  • Protein Kinase Inhibitors
  • Quinazolines
  • Deoxycytidine
  • Cytochrome P-450 Enzyme System
  • Erlotinib Hydrochloride
  • ErbB Receptors
  • Gemcitabine